The Wnt Antagonist, Dickkopf-1, as a Target for the Treatment of Neurodegenerative Disorders

Overview of attention for article published in Neurochemical Research, April 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 57 Dimensions

Readers on

mendeley: 55 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

DKK-1 ANTIBODIES

Application EP-3514173-A1

European Patent Office

Method for treating crohn'S disease or ulcerative colitis by administering a compound…

Grant US-9492419-B2

United States of America

DKK-1 ANTIBODIES

Application EP-2930184-A1

European Patent Office

DKK-1 ANTIBODIES

Application EA-021401-B1

Eurasian Patent Organisation

Compounds and assays for controlling Wnt activity

Grant US-9052324-B2

United States of America

Method for treating inflammation by administering a compound which binds LDL-receptor-relat…

Grant US-9046537-B2

United States of America

DICKKOPF (DKK) PROTEINS AS BIOMARKERS FOR COGNITIVE DECLINE ASSOCIATED WITH ALZHEIMER'S…

Application WO-2015008052-A1

World Intellectual Property Organisation (WIPO)

DKK-1 ANTIBODIES

Application WO-2010117980-A1

World Intellectual Property Organisation (WIPO)